Order Article Reprints

Peña-Jiménez ÁE, Benitez-Aguilar O, Villegas JE, González-de la-Parra M, Delgado-Roche L. Safety and Effectiveness of Naproxen 220 mg + Paracetamol 300 mg + Pamabrom 25 mg Fixed Dose Combination in Women with Premenstrual Syndrome: A Post-Marketing, Open-Label, Uncontrolled, Prospective, Multicenter, Observational Study. Women. 2024; 4(1):13-21. https://doi.org/10.3390/women4010002

Peña-Jiménez, Álvaro E., Omar Benitez-Aguilar, Jesús E. Villegas, Mario González-de la-Parra, and Livan Delgado-Roche. 2024. "Safety and Effectiveness of Naproxen 220 mg + Paracetamol 300 mg + Pamabrom 25 mg Fixed Dose Combination in Women with Premenstrual Syndrome: A Post-Marketing, Open-Label, Uncontrolled, Prospective, Multicenter, Observational Study" Women 4, no. 1: 13-21. https://doi.org/10.3390/women4010002

Peña-Jiménez, Á. E., Benitez-Aguilar, O., Villegas, J. E., González-de la-Parra, M., & Delgado-Roche, L. (2024). Safety and Effectiveness of Naproxen 220 mg + Paracetamol 300 mg + Pamabrom 25 mg Fixed Dose Combination in Women with Premenstrual Syndrome: A Post-Marketing, Open-Label, Uncontrolled, Prospective, Multicenter, Observational Study. Women, 4(1), 13-21. https://doi.org/10.3390/women4010002